Biopharma Senior Sales Specialist

Reporting to the Director Biopharma Sales, EMEAI. This Senior Sales Executive will be responsible for driving strategic growth across complex BioPharma accounts through advanced account mapping, proactive prospecting, and collaborative team-based selling. They will build strategic relationships with pharmaceutical and biotechnology organisations, and deliver sustainable revenue growth across the region.

The successful candidate will work closely with Field Sales and cross-functional colleagues across Business Development, Applications, Technical Support, Marketing, Market Development and Product teams to identify, develop and accelerate high-value Biopharma opportunities.

Key Responsibilities

Execute the EMEAI Biopharma commercial strategy, delivering against revenue and growth targets.

In line with the Director Biopharma Sales develop and create complex and comprehensive account plans that expand adoption across stakeholders, applications, departments and sites.

Own deal strategy for key accounts in the region, with national or global scope where required, positioning Oxford Nanopore Technologies as a strategic technology partner.

Build and manage a strong pipeline across pharmaceutical, biotechnology, CRO, CDMO and other strategic Biopharma customers.

Develop senior and executive-level relationships within key accounts

Identify high-value opportunities for nanopore sequencing across drug discovery and development, translational research, biomarker development, cell and gene therapy, vaccines, multi-omics and emerging Biopharma applications, associated with R&D, analytical development and QC.

Translate customer evaluations and pilot projects into scaled, routine and repeatable use of Oxford Nanopore technology.

Identify and develop strategic partnerships and customer-led projects that create new commercial opportunities.

Partner closely with Field Sales teams to drive coordinated account strategy and execution across EMEAI.

Manage and maintain strong pipeline management, forecasting and commercial discipline, providing clear visibility of performance and future growth.

Capture customer, market and competitive insights to help influence commercial strategy, product development and market positioning.

Represent Oxford Nanopore Technologies at strategic customer meetings, industry conferences and relevant Biopharma forums delivering high- impact technical presentations, workshops and seminars aligned to customer and internal needs.

You will be an experienced senior commercial professional with a strong understanding of the pharmaceutical and biotechnology sector and a track record of developing complex, strategic customer relationships and delivering revenue growth.

You will combine strategic thinking with hands-on commercial execution, be comfortable engaging stakeholders from scientists through to senior executives and be highly effective at influencing and coordinating across a matrix organisation.

Experience working with cross-functional teams to deliver and execute strategic deals.

A few years experience in genomics, sequencing, life sciences tools or technologies supporting pharmaceutical R&D would be highly advantageous.

This is an opportunity to play a significant role in expanding the use of Oxford Nanopore Technologies across the EMEAI Biopharma market, developing strategic customer partnerships and establishing nanopore sequencing as an increasingly important technology across pharmaceutical and biotechnology research and development.

Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.

#LI-JR1

#LI-hybrid

Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.